BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20434462)

  • 21. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
    Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
    Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic coupling between the SH2 domain and active site of the COOH terminal Src kinase, Csk.
    Wong L; Lieser S; Chie-Leon B; Miyashita O; Aubol B; Shaffer J; Onuchic JN; Jennings PA; Woods VL; Adams JA
    J Mol Biol; 2004 Jul; 341(1):93-106. PubMed ID: 15312765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
    Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
    Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk between the catalytic and regulatory domains allows bidirectional regulation of Src.
    Gonfloni S; Weijland A; Kretzschmar J; Superti-Furga G
    Nat Struct Biol; 2000 Apr; 7(4):281-6. PubMed ID: 10742171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of the carboxyl-terminal Src kinase, Csk.
    Ogawa A; Takayama Y; Sakai H; Chong KT; Takeuchi S; Nakagawa A; Nada S; Okada M; Tsukihara T
    J Biol Chem; 2002 Apr; 277(17):14351-4. PubMed ID: 11884384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic identification of ZO-1/2 as a novel scaffold for Src/Csk regulatory circuit.
    Saito K; Enya K; Oneyama C; Hikita T; Okada M
    Biochem Biophys Res Commun; 2008 Feb; 366(4):969-75. PubMed ID: 18086565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of C-terminal Src kinase (Csk) by phosphorylation at serine-364 depends on the Csk-Src homology 3 domain.
    Yaqub S; Abrahamsen H; Zimmerman B; Kholod N; Torgersen KM; Mustelin T; Herberg FW; Taskén K; Vang T
    Biochem J; 2003 May; 372(Pt 1):271-8. PubMed ID: 12600271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).
    Lee S; Ayrapetov MK; Kemble DJ; Parang K; Sun G
    J Biol Chem; 2006 Mar; 281(12):8183-9. PubMed ID: 16439366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine.
    Lamers MB; Antson AA; Hubbard RE; Scott RK; Williams DH
    J Mol Biol; 1999 Jan; 285(2):713-25. PubMed ID: 9878439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the N-terminal regulatory region reduce the catalytic activity of Csk, but do not affect its recognition of Src.
    Sun G; Budde RJ
    Arch Biochem Biophys; 1999 Jul; 367(2):167-72. PubMed ID: 10395732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.
    LaFevre-Bernt M; Sicheri F; Pico A; Porter M; Kuriyan J; Miller WT
    J Biol Chem; 1998 Nov; 273(48):32129-34. PubMed ID: 9822689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
    Pletneva EV; Sundd M; Fulton DB; Andreotti AH
    J Mol Biol; 2006 Mar; 357(2):550-61. PubMed ID: 16436281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells.
    Cloutier JF; Veillette A
    EMBO J; 1996 Sep; 15(18):4909-18. PubMed ID: 8890164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases.
    Huang K; Wang YH; Brown A; Sun G
    J Mol Biol; 2009 Mar; 386(4):1066-77. PubMed ID: 19244618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The folding kinetics and thermodynamics of the Fyn-SH3 domain.
    Plaxco KW; Guijarro JI; Morton CJ; Pitkeathly M; Campbell ID; Dobson CM
    Biochemistry; 1998 Feb; 37(8):2529-37. PubMed ID: 9485402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.